Table 1.
Patient characteristics
| Variables | n = 16 |
| Age, years | 42 ± 16 |
| Sex | |
| Female, n (%) | 10 (63) |
| BMI, kg/m2 | 22 ± 3 |
| SpO2, % | 98 ± 1 |
| Smoking, n (%) | 8 (50) |
| Influenza vaccine, n (%) | 9 (56) |
| BCG, n (%) | 15 (94) |
| Underlying disease | |
| Hypertension, n (%) | 3 (19) |
| Diabetes mellitus, n (%) | 1 (6) |
| Dyslipidemia, n (%) | 3 (19) |
| Hyperuricemia, n (%) | 2 (13) |
| Medications | |
| Oseltamivir, n (%) | 16 (100) |
| Levofloxacin, n (%) | 14 (88) |
| Garenoxacin, n (%) | 1 (6) |
| Amoxicillin/clavulanic acid, n (%) | 1 (6) |
| Acetaminophen, n (%) | 4 (25) |
| Probiotics (MIYA-BM), n (%) | 4 (25) |
BMI body mass index, SpO2 peripheral capillary oxygen saturation, BCG Bacille de Calmette et Guérin, MIYA-BM the probiotic drug that contains Clostridium butyricum MIYAIRI 588